Best Healthcare Research Agencies in Poland
Assess top healthcare research agencies in Poland for 2026. Find verified medical panels, clinical trial support, and expert patient insights for your studies.
Quick answer
For complex clinical data and commercial strategy, IQVIA; for multi-country patient journey mapping, Ipsos Healthcare; for rapid, high-volume fieldwork and local Polish insights, Global Vox Populi; for specialized qualitative recruitment and regional Eastern European coverage, Stratega Market Research.
Selecting the right partner among healthcare research agencies in Poland requires balancing access to niche medical audiences with rigorous data quality standards. Pharmaceutical, medtech, and provider organizations operating in this region face specific challenges, including strict data protection regulations and the need for high-quality, verified stakeholder feedback.
This assessment examines the capabilities of seven research providers to help insights directors and procurement leads align their research requirements with the appropriate partner. Whether your objective is to map complex patient pathways, evaluate market entry, or monitor brand performance, understanding the distinction between generalist data collectors and healthcare-specialized research partners is essential for success in the 2026 market.
Best Healthcare Research Agencies in Poland: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA Poland | Large-scale clinical development and real-world evidence | 88.5 |
| 2 | Ipsos Healthcare | Multi-country healthcare trend and journey mapping | 86.0 |
| 3 | Global Vox Populi | Hard-to-reach patient and physician recruitment | 82.5 |
| 4 | Kantar Health | Brand growth and consumer-side healthcare insights | 80.5 |
| 5 | BioStat | Clinical trial support and medical data analytics | 80.0 |
| 6 | Stratega Market Research | Qualitative recruitment in Eastern Europe | 74.5 |
| 7 | AQR Fieldwork | Specialized recruitment for medical fieldwork | 67.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA Poland | Pharma leaders, clinical sites, patients | Internal site and data quality controls | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos Healthcare | Doctors, patients, citizens, customers | Not stated on pages reviewed | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, patients, payers, providers | Multi-point validation against registries and associations | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 30,852 healthcare professionals; 62,598 nurses and allied health professionals; 1,005,227 patient profiles (in Poland; Global Vox Populi panel records, Oct 2026) | Not published |
| Kantar Health | Consumers, healthcare buyers | Qubed AI and deep neural networks | Not stated on pages reviewed | Not published | Not published | Not published |
| BioStat | Patients, medical professionals | Regular profile checks and response time monitoring | Not stated on pages reviewed | Not published | Not published | Not published |
| Stratega Market Research | Physicians, medical professionals, B2B decision-makers | Strict validation procedure and quality check system | ESOMAR | Not published | 17,000 healthcare professionals (strategaresearch.com, Oct 2026) | Not published |
| AQR Fieldwork | Physicians, nurses, lab technicians, patients | Internal data protection officer oversight | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA Poland | ● | – | – | ● | – | – |
| Ipsos Healthcare | ● | ● | – | ● | – | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Kantar Health | ● | ● | ● | ● | – | ● |
| BioStat | ● | ● | ● | ● | – | – |
| Stratega Market Research | ● | ● | ● | ● | ● | – |
| AQR Fieldwork | ● | ● | ● | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Rigorous evaluation criteria make sure that your chosen research partner can meet the demanding requirements of health and life-sciences studies in Poland.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the provider's depth of knowledge in the life-sciences sector. Good agencies demonstrate understanding of therapeutic areas, regulatory environments, and the specific dynamics of the Polish healthcare system, making sure that research instruments are medically accurate and relevant to the target respondent groups. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO standards, GDPR, and specific healthcare codes like BHBIA. For Polish healthcare research, the agency must demonstrate solid procedures for data protection, informed consent, and the mandatory reporting of any adverse events or product complaints during the study. |
| Target Audience Reach | 15 | This assesses the ability to access specific stakeholders such as specialists, nurses, and patients. A high-scoring agency provides granular profiling and confirms feasibility for hard-to-reach groups in Poland, making sure the recruited sample is representative and accurately reflects the medical reality of the study. |
| Research Quality | 10 | This looks at the rigour of sampling and design. High-quality research in this field requires strict validation of respondent identities to prevent fraud, along with questionnaire design that avoids bias and protects high completion rates among busy medical professionals and patients. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This gauges the range of available research methods. A versatile agency offers both qualitative and quantitative approaches, including online panels, CATI, and in-depth interviews, allowing the researcher to select the best methodology to address the specific objectives of the healthcare project. |
| Analytical Capability | 5 | This measures the ability to translate raw data into actionable business findings. The agency should demonstrate experience in advanced analytics, segmentation, and reporting that clearly supports strategic decisions regarding product positioning, market access, or patient experience improvements. |
| Client Service and Speed | 5 | This assesses responsiveness and project management effectiveness. In the fast-paced Polish pharmaceutical market, agencies must provide clear communication, proactive issue resolution, and the ability to manage tight timelines without compromising the integrity of the data collection process. |
| Pricing and Feasibility Transparency | 5 | This evaluates the clarity of project proposals. A reputable partner provides honest assessments of feasibility and incidence rates early in the process, making sure that the scope and cost of the research are aligned with the actual possibilities of the Polish market. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in Poland
IQVIA Poland: best for large-scale clinical development and real-world evidence
Strongest fitLarge-scale pharmaceutical companies needing deep clinical and commercial data.
IQVIA Poland provides a sophisticated suite of solutions for the life sciences sector, integrating data, technology, and clinical expertise. Their presence in Poland is significant, supporting pharmaceutical and biotech organizations with comprehensive insights ranging from clinical trial management to commercial execution.
The company focuses on transforming life sciences through advanced analytics and high-grade data. Their approach is designed to reduce risk and accelerate decision-making, making them a primary choice for complex, data-heavy research requirements.
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- Clinical Development: Full-service clinical trial solutions and site identification powered by proprietary data.
- Commercial Analytics: Strategic intelligence, market modeling, and performance benchmarking for pharmaceutical assets.
- Real-World Evidence: Generation of evidence to support market access and demonstrate product value.
Strengths
- Data Network: Access to vast proprietary databases and non-identified patient records to drive insights.
- Technological Integration: Unified platforms and AI-driven solutions to optimize trial operations and commercial strategy.
- Expertise: Deep institutional knowledge and specialized teams for pharmacovigilance and lifecycle safety.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform designed to accelerate innovation and optimize clinical development.
- Predictive Modeling: Uses life science models to predict market trends and clinical outcomes.
Impact on businesses
- Asset Success: Maximizes the value and probability of success for pharmaceutical assets.
- Operational Efficiency: Reduces trial bottlenecks and improves decision-making speed.
Why it may fit your brief
IQVIA is best for complex, data-intensive projects where large-scale evidence is required. Smaller, qualitative-focused studies may find their approach overly complex.
Ipsos Healthcare: best for multi-country healthcare trend and journey mapping
Strongest fitGlobal organizations requiring multi-country insights on healthcare trends and patient experience.
Ipsos Healthcare provides specialized research solutions aimed at understanding the complex dynamics of healthcare systems and stakeholder opinions. Their presence in Poland includes a focus on tracking patient experiences and physician perspectives on health issues.
The agency is known for its ability to provide global insights while maintaining local relevancy. Their work often centers on large-scale trends, helping clients work through shifting healthcare environments and improve decision-making through reliable data.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Market Strategy: Understanding market dynamics and health system performance.
- Brand Tracking: Monitoring brand health and performance across key markets.
- Patient Journey Mapping: Analyzing the patient experience to guide service improvements.
Strengths
- Global Perspective: Provides exceptional snapshots of world opinion on pressing health issues.
- Expertise: Specialized teams focused on doctors, patients, and health systems.
- Actionable Insights: Turns complex data into actionable truth for better decision-making.
Innovation and technology
- AI Integration: Uses AI tools to deliver faster and more consistent insights.
- Health Service Reports: Proprietary tracking indexes for healthcare quality and access.
Impact on businesses
- Better Decisions: Supports smarter and faster decisions across various health markets.
- System Understanding: Provides clarity on health system capacity and patient needs.
Why it may fit your brief
Strong for large-scale tracking and systemic studies. For niche, highly local Polish clinical research, smaller specialized agencies might provide more tailored support.
Global Vox Populi: best for hard-to-reach patient and physician recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitResearch projects requiring high-precision recruitment of medical specialists or specific patient populations in Poland.
Global Vox Populi offers a dedicated approach to primary research, using its own proprietary panels and localized fieldwork to support pharmaceutical and medtech clients. Its presence in Poland is built on a foundation of verified medical databases, making sure that research projects are grounded in high-quality data.
The agency provides specialized support for healthcare-specific research, emphasizing compliance and data integrity. By maintaining its own panels, the firm avoids the reliability issues often associated with open-market sampling, making it a reliable partner for researchers needing high-precision data in Poland.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Poland
30,852 panellists
- Primary & General10,736
- Internal Medicine Subspecialties3,544
- Surgical Specialties2,704
- Diagnostic & Laboratory2,366
- Acute, Peri-operative & Critical Care2,094
- Women's & Reproductive Health1,990
Nurses and allied health panel, in Poland
62,598 panellists
- Registered Nurses23,007
- Advanced Practice Nurses1,134
- Licensed / Practical / Enrolled Nurses3,609
- Nursing Support (Aides / HCAs)1,569
- Midwives2,247
- Pharmacists & Pharmacy Techs3,412
Patient panel, in Poland
1,005,227 patient profiles
- Aesthetics & Cosmetic321,141
- Cardiovascular84,453
- Ophthalmology57,645
- Endocrinology & Metabolic53,998
- Dermatology49,443
- Women's Health47,643
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Poland
1,130 panellists
- Provider: Access & Administrative Roles678
- Payer: Access & Coverage Roles452
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- Proprietary Panel Management: Access to 30,852 healthcare professionals and 62,598 nurses and allied health professionals in Poland.
- Patient Research: Access to over 1,000,000 patient profiles across therapeutic areas including cardiovascular, ophthalmology, and dermatology.
- Fieldwork Execution: Comprehensive data collection using CATI, CAPI, and online methodologies tailored for the Polish medical market.
- Payer and Provider Access: Direct access to 1,130 payers and providers for market access and administrative research in Poland.
Strengths
- Verified Medical Panels: Panels are recruited via professional associations and registries with rolling validation of clinical credentials.
- Data Quality Standards: Implements de-duplication, fingerprinting, and straight-lining detection to protect high-quality, authentic completes.
- Regulatory Compliance: Operates under ISO 9001, 20252, and 27001 certifications with strict adherence to HIPAA and GDPR.
- Adverse Event Handling: Processes product complaints and adverse events according to established BHBIA guidance.
Innovation and technology
- Proprietary Platform: Surveys are hosted on the firm’s own platform, protecting full control over data flow and security.
- Mobile-First Methodology: Uses mobile and WhatsApp-assisted survey tools to reach busy medical professionals in Poland.
Impact on businesses
- Strategic Decision Support: Provides high-confidence data that supports product launch and market access strategies.
- Patient Journey Insights: Enables better understanding of treatment pathways, leading to improvements in patient experience and outcomes.
Why it may fit your brief
The firm is ideal when data quality and verified respondent identity are the primary concerns. For projects that strictly require a generalist agency with a broad consumer focus, other providers may be more relevant.
Kantar Health: best for brand growth and consumer-side healthcare insights
Strongest fitHealthcare brands focusing on consumer-facing marketing and brand tracking.
Kantar uses its global brand equity studies and consumer data to support healthcare companies in Poland. Their focus is on understanding human behavior to drive brand growth and product adoption, using a mix of survey solutions and advanced analytics.
With a large network and proprietary panels, they offer consistent data quality and fast turnaround times. Their approach centers on connecting consumer insights with business outcomes, making them a strong partner for market-facing healthcare research.
Scorecard: 80.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.5 |
Core services
- Brand Strategy: Brand growth modeling and valuation based on global consumer data.
- Survey Solutions: Custom and omnibus surveys for gathering feedback from customers and non-customers.
- Audience Activation: Digital audience validation and targeting to support media strategy.
Strengths
- Data Quality: Qubed AI technology detects fraud and protects respondent integrity.
- Global Reach: Access to proprietary premium panels across multiple markets.
- Agility: Fast turnaround options through omnibus surveys and templated solutions.
Innovation and technology
- Qubed AI: Proprietary anti-fraud technology that identifies fraudulent behavior in real-time.
- Kantar Marketplace: An agile research platform combining survey tools with powerful analytics.
Impact on businesses
- Brand Growth: Helps brands build profitable and sustainable market positions.
- Marketing ROI: Optimizes advertising and media spend through validated consumer insights.
Why it may fit your brief
Ideal for brand-centric studies that require large-sample consumer insights. For highly specialized clinical or physician-led research, other firms may offer deeper domain expertise.
BioStat: best for clinical trial support and medical data analytics
Strongest fitPharmaceutical and medical organizations in Poland needing clinical trial and market research support.
BioStat operates as a research and development center with a deep focus on the Polish medical and pharmaceutical sectors. They provide comprehensive services ranging from clinical trial support to market research, using their own platforms for data collection.
Their expertise in statistics and medical research positions them as a strong partner for organizations needing rigorous data analysis alongside traditional market research. Their approach is rooted in providing reliable, evidence-based solutions for health-sector clients.
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | biostat.com.pl (3 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Clinical Research: Full-service CRO capabilities including statistics and trial management.
- Market Research: Conducting mystery shopping, surveys, and quality of service studies for pharma.
- Statistical Analysis: Advanced statistical processing for medical and epidemiological data.
Strengths
- Technical Expertise: Strong foundation in clinical research and statistical methodology.
- Proprietary Panel: Access to a large consumer and medical panel for rapid data collection.
- Specialization: Focused experience within the Polish pharmaceutical and medical market.
Innovation and technology
- Internet Research Panel: Proprietary panel with over 200,000 respondents for rapid survey execution.
- Digital Tools: Uses mobile solutions and multimedia surveys to capture honest feedback.
Impact on businesses
- Strategic Direction: Provides solutions that guide business decisions for pharmaceutical companies.
- Product Development: Helps in the refinement of concepts, prototypes, and advertising campaigns.
Why it may fit your brief
BioStat is highly relevant for medical-specific research in Poland. If a project requires primarily international consumer-brand expertise, other agencies may be more suitable.
Stratega Market Research: best for qualitative recruitment in Eastern Europe
Strongest fitOrganizations needing qualitative research and fieldwork across Poland and Eastern Europe.
Stratega Market Research provides a range of research services with a specific emphasis on Eastern European markets. Their healthcare division is supported by a large proprietary panel of medical professionals, enabling them to execute complex qualitative and quantitative studies.
The agency is positioned as a flexible partner for international research firms and consulting companies, offering localized fieldwork and recruitment expertise. Their focus on high-quality data collection makes them a capable partner for challenging medical research projects.
Scorecard: 74.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.5 |
Core services
- Qualitative Recruitment: Recruitment for focus groups and in-depth interviews in Poland and Eastern Europe.
- Healthcare Panel: Access to a dedicated panel of over 17,000 verified healthcare professionals.
- Data Collection: Full fieldwork services including CATI, online, and face-to-face interviews.
Strengths
- Regional Coverage: Established networks across Eastern Europe including Romania, Czech Republic, and Hungary.
- Quality Control: Strict validation procedures for all physicians and medical professionals recruited.
- Versatility: Handles both standalone full-service research and local fieldwork-only projects.
Innovation and technology
- Healthcare Panel: A verified panel of 17,000+ professionals for challenging medical research.
- Methodological Mix: Uses ethnographic techniques and face-to-face interviews to gain deep insights.
Impact on businesses
- Market Entry: Supports investment and commercial decisions in Eastern European markets.
- Decision-Maker Mapping: Identifies and verifies key influencers within complex healthcare organizations.
Why it may fit your brief
Stratega is highly effective for qualitative recruitment. For large-scale quantitative tracking or clinical trial management, other firms may offer more specialized infrastructure.
AQR Fieldwork: best for specialized recruitment for medical fieldwork
Strongest fitResearch projects needing specific recruitment of allied healthcare professionals and niche medical groups.
AQR Fieldwork focuses on high-quality recruitment and data collection, serving as a fieldwork partner for various research projects. They possess specific expertise in reaching specialized medical audiences, from pharmacy directors to lab technicians.
The company offers a range of methodologies, including central location tests and telephone interviews, to gather relevant data for their clients. Their focus on the recruitment of project-specific target groups makes them a useful partner for specialized fieldwork requirements.
Scorecard: 67.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 67.0 |
Core services
- Fieldwork Services: Data collection via CATI, online surveys, and face-to-face interviews.
- Specialized Recruitment: Recruiting niche audiences for medical, B2B, and consumer research.
- Central Location Testing: Managing product and sensory tests at physical locations.
Strengths
- Recruitment Expertise: Ability to recruit niche healthcare groups, including nurses and lab technicians.
- Methodological Range: Comprehensive fieldwork capabilities across multiple formats.
- Accessibility: Maintains a healthcare research panel for direct access to medical professionals.
Innovation and technology
- CATI Design: Advanced telephone interviewing for difficult-to-reach audiences.
- Global Capabilities: Experienced in conducting central location testing across different international regions.
Impact on businesses
- Relevant Data: Provides actionable insights through targeted respondent recruitment.
- Actionable Reporting: Supports clients with data analysis and preparation of research reports.
Why it may fit your brief
AQR is a strong fieldwork partner for recruitment-heavy studies. For research requiring deep strategic consulting or advanced clinical analysis, other providers may be better suited.
How HCP and patient verification actually works in Poland
Rigorous verification of healthcare professionals and patients is the only way to protect the validity of research findings in Poland.
Professional Credential Validation
For healthcare professionals in Poland, verification must include checking professional registration numbers against official medical registries or nursing databases. Agencies should perform this at the time of recruitment and maintain a rolling re-validation process. Ask the provider to confirm the frequency of their database updates and whether they cross-reference against current practicing status, as this makes sure your data comes from active, qualified professionals rather than expired contacts.
Identity and Fraud Detection
Beyond credentials, agencies should use digital fingerprinting to detect duplicate accounts and prevent fraudulent panellists from participating in multiple studies. This involves checking for consistent IP addresses, device identifiers, and browser signatures. Request documentation on their de-duplication processes and how they handle respondents who provide contradictory demographic information across different surveys, which is a common red flag for automated or fraudulent activity in the Polish research market.
Behavioural Quality Checks
During fieldwork, agencies should implement trap questions, straight-lining detection, and time-tracking to monitor completion quality. A reliable partner will remove respondents who finish surveys too quickly or provide nonsensical open-ended responses. Make sure the agency provides a transparent report on the percentage of completes removed for quality issues, as this level of detail confirms that they prioritize data integrity over raw volume.
Data Privacy and Consent
All healthcare research must comply with GDPR and local Polish law, making sure that patient consent is explicit, informed, and revocable. Verify that the agency uses a double opt-in process for all panel members. You should ask for proof that they have clear, accessible procedures for respondents to view, correct, or remove their data at any time, as this is a core requirement for compliant research in the European Union.
How to choose the right provider in Poland
Selecting a partner requires a clear match between your study's complexity and the agency's specific panel and methodological strengths.
- Define Research Objectives: Start by identifying if your project is a clinical, commercial, or public health study. A specialist agency will have the language and regulatory knowledge required for that specific category.
- Assess Panel Ownership: Check if the agency owns its panels or rents them. Owned panels offer higher data quality and better control over respondent verification than rented lists.
- Review Regulatory Capability: Make sure the agency has established procedures for adverse event reporting. This is non-negotiable for any pharmaceutical or medtech research.
- Check Regional Experience: If your study extends beyond Poland, verify the agency's ability to manage fieldwork across the target countries. Look for consistent quality controls across all locations.
- Request Feasibility Proof: Ask for a feasibility check for your target audience early in the process. A good partner will be honest about the availability of hard-to-reach specialists or patients.
Questions to ask before you commission
- How do you verify the medical credentials of your physician and nurse panellists in Poland?
- What is your specific procedure for reporting adverse events or product complaints during a study?
- Can you provide a breakdown of your panel size for my specific target specialty or patient condition?
- What automated and manual quality checks do you perform to prevent fraudulent completions?
- How do you protect GDPR compliance when handling sensitive health data in the Polish market?
- What is your process for managing complex, low-incidence recruitment for rare-disease patient groups?
Common pitfalls to avoid
- Relying on Generalist Panels: Using general consumer panels for medical research often leads to poor data quality and misrepresented respondent profiles.
- Ignoring AE Reporting: Failing to establish a clear adverse event reporting protocol can create significant regulatory and legal risks for the sponsor.
- Overlooking Local Context: Treating the Polish healthcare market as identical to other European markets ignores specific local regulations and physician behaviors.
- Lack of Verification: Accepting respondents without checking professional registrations increases the risk of receiving non-expert or fraudulent data.
What a feasibility check should include
A professional feasibility check is the foundation of any successful healthcare study in Poland.
Target Audience Definition
A proper check must clearly define the required professional specialty or patient profile. This makes sure the agency can realistically access the group you need for your study.
Incidence Rate Estimation
The check should provide a realistic estimate of how many potential respondents fit your criteria. This avoids surprises during the fieldwork phase and helps manage timelines.
Recruitment Strategy
Your partner should outline how they will reach the target group. For niche audiences, this might involve professional associations or targeted outreach.
Timeline Validation
The feasibility check must confirm that the recruitment goals can be met within your required timeframe. If the timeline is too ambitious, a good partner will propose a more achievable approach.
Conclusion
Choosing among healthcare research agencies in Poland is a strategic decision that directly impacts the reliability of your insights. Organizations requiring high-volume clinical data or commercial analytics should prioritize partners with deep technological integration and large-scale data assets. Conversely, for projects focused on patient journeys, qualitative explorations, or niche medical specialists, agencies that own verified, proprietary panels will provide the most accurate and actionable results.
Use the scorecard above to match your specific study needs with the strengths of each provider. Make sure that your final selection is based not just on price, but on the agency’s ability to demonstrate rigorous compliance, identity verification, and deep knowledge of the Polish healthcare environment. A well-vetted partner will serve as an extension of your insights team, reducing risk and supporting confident decision-making throughout your research project.
Planning research in Poland? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which are the top healthcare market research agencies in Poland?
The market includes global leaders like IQVIA and Ipsos Healthcare, which are suited for large-scale and multi-country studies, as well as specialized providers like Global Vox Populi, BioStat, Stratega, and AQR Fieldwork. The best choice depends on whether you need large-scale commercial data, clinical trial support, or highly specific qualitative recruitment.
Do international healthcare research firms operate in Poland?
Yes, major international firms maintain established entities in Poland to provide localized research. These firms typically offer a combination of global research standards and local market knowledge, making sure that studies meet both international quality benchmarks and local regulatory requirements for the Polish healthcare sector.
What methods are used for pharmaceutical market research in Poland?
Methods include quantitative online surveys, CATI, and CAPI, alongside qualitative approaches like focus groups, in-depth interviews, and ethnography. Agencies also use proprietary panels and advanced analytics to map patient journeys and monitor brand performance, making sure methodologies are tailored to the specific stakeholder group being researched.
How to find a reliable healthcare market research partner in Poland?
Look for partners with clear certifications such as ISO 9001 and ISO 20252, and those who demonstrate strict adherence to GDPR and BHBIA guidelines. Reliability is best proven by the agency's ability to verify respondent credentials and their transparency regarding feasibility, incidence rates, and data quality processes.
Are there healthcare-specific research panels in Poland?
Yes, several agencies maintain proprietary healthcare-specific panels in Poland. These panels consist of verified physicians, nurses, and allied health professionals, as well as patient profiles. Using these dedicated panels is highly recommended over generalist consumer panels to protect the accuracy and relevance of your medical research data.
What is the role of the Medical Research Agency in Poland for research firms?
The Medical Research Agency in Poland is a state body that supports the development of clinical research and the medical sector. While research agencies operate independently, they often align their practices with the broader regulatory and ethical standards promoted by such institutions to protect the safety and validity of clinical and market research.
What is the most important factor in healthcare data quality?
The most important factor is the verification of the respondent's identity and professional credentials. Making sure that you are speaking to the correct target audience, such as a specific type of physician, is critical for the validity of healthcare insights. Agencies that use multi-point validation against official registries provide the highest quality data.
How do I handle adverse events in research?
You must establish a formal adverse event reporting protocol with your research partner before fieldwork begins. This protocol must follow BHBIA guidance and make sure that any product complaints or health issues reported by respondents are immediately documented and communicated to the client for regulatory follow-up.